Stock listing
ACE Stock Price, News, Filings & Events — Ascelia Pharma Ab
Selected listing: ACE · OMXSTO · SEK · SE
This page tracks Ascelia Pharma Ab's ACE:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACE:OMXSTO. ACE:OMXSTO is the stock-level entry point for investors researching Ascelia Pharma Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ascelia Pharma AB, trading under the ticker ACE, is a public company based in Sweden. The company has a market capitalization of approximately 6.94 million USD. Ascelia Pharma focuses on developing innovative treatments in the pharmaceutical sector.
- Ticker
- ACE:OMXSTO
- Asset type
- Stock
- Market cap
- $8.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK
Ascelia Pharma Ab ACE:OMXSTO stock context
This page tracks Ascelia Pharma Ab's ACE:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACE:OMXSTO. ACE:OMXSTO is the stock-level entry point for investors researching Ascelia Pharma Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ascelia Pharma AB, trading under the ticker ACE, is a public company based in Sweden. The company has a market capitalization of approximately 6.94 million USD. Ascelia Pharma focuses on developing innovative treatments in the pharmaceutical sector.
Latest news from Ascelia Pharma Ab
Ascelia Pharma Announces Organizational Changes and a Reduced Cost Base
July 15, 2026
Ascelia Pharma Provides Update on the Orviglance NDA
July 3, 2026
Ascelia Pharma Expands Orviglance IP Portfolio with New Patent Filing
June 30, 2026
Ascelia Pharma Carries Out a Directed Share Issue of SEK 20 Million
April 23, 2026
Notice of Annual General Meeting in Ascelia Pharma AB
March 30, 2026
Ascelia Pharma Ab earnings calls
Ascelia Pharma AB (publ) (ACE) Q2 2026 Earnings Call
August 20, 2026 · Replay with transcript and chapters
Ascelia Pharma AB (publ) (ACE) Q1 2026 Earnings Call
May 12, 2026 · Replay with transcript and chapters
Ascelia Pharma AB (publ) (ACE) Q4 2025 Earnings Call
February 5, 2026 · Replay with transcript and chapters
Ascelia Pharma AB (publ) (ACE) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Ascelia Pharma AB (publ) (ACE) Q2 2025 Earnings Call
August 22, 2025 · Replay with transcript and chapters
Ascelia Pharma AB (publ) (ACE) Q1 2025 Earnings Call
May 16, 2025 · Replay with transcript and chapters
Research Ascelia Pharma Ab
Ascelia Pharma Ab investor report
Review AI stock analysis and investor report context for ACE:OMXSTO.
Ascelia Pharma Ab company profile
View the public company page for Ascelia Pharma Ab on 6ix.
Ascelia Pharma Ab news
Read company news and market updates connected to Ascelia Pharma Ab.
Ascelia Pharma Ab investor events
Find investor webinars, events, and replay context for Ascelia Pharma Ab.
Alternate listings
ACES:AQUISEU
GB · SEK
Alternate listing for Ascelia Pharma Ab; the primary context on this page is ACE:OMXSTO.
ACES:AQUISUK
GB · SEK
Alternate listing for Ascelia Pharma Ab; the primary context on this page is ACE:OMXSTO.
7ZA:FWB
DE · EUR
Alternate listing for Ascelia Pharma Ab; the primary context on this page is ACE:OMXSTO.